The controlling shareholder of Novo Nordisk has joined a coalition of European venture capital firms to mobilise increased funding amidst concerns that Europe’s life sciences sector may fall behind its
The controlling shareholder of Novo Nordisk has joined a coalition of European venture capital firms to mobilise increased funding amidst concerns that Europe’s life sciences sector may fall behind its
The Swiss pharmaceutical giant Roche has announced a partnership with Danish biotechnology firm Zealand Pharma in a deal valued at up to $5.3 billion. The collaboration aims to develop and






